ANGO News and Press, AngioDynamics Inc. From 01/06/26

2026-01-06 06:30:20 ET More on AngioDynamics AngioDynamics: Growth Remains Under The Radar AngioDynamics, Inc. (ANGO) Presents at UBS Global Healthcare Conference 2025 Transcript AngioDynamics FQ2 2026 Earnings Preview Seeking Alpha’s Quant Rating on A...

Penguin Solutions Inc. (PENG) is expected to report $0.25 for Q1 2026 AAR Corp. (AIR) is expected to report $1.02 for Q2 2026 AngioDynamics Inc. (ANGO) is expected to report $-0.1 for Q2 2026

Med Tech segment delivers fifth consecutive quarter of double-digit growth Strong adjusted EBITDA; and positive cash flow Three regulatory milestones support Mechanical Thrombectomy portfolio: Modified AlphaVac 510(k) clearance, PAVE and APEX-Return IDE approvals Raised full year FY 2...

2026-01-05 11:25:44 ET More on AngioDynamics AngioDynamics: Growth Remains Under The Radar AngioDynamics, Inc. (ANGO) Presents at UBS Global Healthcare Conference 2025 Transcript Seeking Alpha’s Quant Rating on AngioDynamics Historical earnings data fo...

2025-12-29 18:47:22 ET Slow progress is still progress, and although AngioDynamics ( ANGO ) arguably still does not get its due in the market, the company continues to execute at an improved level. Solid growth in the faster-growing Medical Tech segment remains the key driver, as the co...

AngioDynamics, Inc. (NASDAQ: ANGO), a leading and transformative medical technology company focused on restoring healthy blood flow in the body’s vascular system, expanding cancer treatment options and improving patient quality of life, today announced that it will report financial results...

AngioDynamics, Inc. (NASDAQ: ANGO), a medical technology company focused on restoring healthy blood flow in the body's vascular system, expanding cancer treatment options and improving patient quality of life, today announced, that Jim Clemmer, President and Chief Executive Officer, and Stephen T...

2025-11-10 10:31:36 ET AngioDynamics, Inc. (ANGO) UBS Global Healthcare Conference 2025 November 10, 2025 8:00 AM EST... Read the full article on Seeking Alpha For further details see: AngioDynamics, Inc. (ANGO) Presents at UBS Global Healthcare Conference 2025 Transcript

AngioDynamics, Inc. (NASDAQ: ANGO), a medical technology company focused on restoring healthy blood flow in the body's vascular system, expanding cancer treatment options and improving patient quality of life, today announced, that Jim Clemmer, President and Chief Executive Officer, and Stephen T...

Function-Preserving Therapy Recognized in the Medical Devices Category for its Use of Irreversible Electroporation (IRE) Technology in Treatment of Prostate Tumors AngioDynamics, Inc. (NASDAQ: ANGO), a medical technology company focused on restoring healthy blood flow in the body's vasc...